These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 3439707

  • 1. Measurement of phosphocreatine to ATP ratio in normal and diseased human heart by 31P magnetic resonance spectroscopy using the rotating frame-depth selection technique.
    Rajagopalan B, Blackledge MJ, McKenna WJ, Bolas N, Radda GK.
    Ann N Y Acad Sci; 1987; 508():321-32. PubMed ID: 3439707
    [Abstract] [Full Text] [Related]

  • 2. Quantitative studies of human cardiac metabolism by 31P rotating-frame NMR.
    Blackledge MJ, Rajagopalan B, Oberhaensli RD, Bolas NM, Styles P, Radda GK.
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4283-7. PubMed ID: 3473502
    [Abstract] [Full Text] [Related]

  • 3. Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by 31P magnetic resonance spectroscopy.
    Yabe T, Mitsunami K, Inubushi T, Kinoshita M.
    Circulation; 1995 Jul 01; 92(1):15-23. PubMed ID: 7788910
    [Abstract] [Full Text] [Related]

  • 4. Proton Overhauser enhancements in human cardiac phosphorus NMR spectroscopy at 1.5 T.
    Bottomley PA, Hardy CJ.
    Magn Reson Med; 1992 Apr 01; 24(2):384-90. PubMed ID: 1569877
    [Abstract] [Full Text] [Related]

  • 5. 31P nuclear magnetic resonance spectroscopic imaging of regions of remodeled myocardium in the infarcted rat heart.
    Friedrich J, Apstein CS, Ingwall JS.
    Circulation; 1995 Dec 15; 92(12):3527-38. PubMed ID: 8521576
    [Abstract] [Full Text] [Related]

  • 6. Analysis of rat heart in vivo by phosphorus nuclear magnetic resonance.
    Grove TH, Ackerman JJ, Radda GK, Bore PJ.
    Proc Natl Acad Sci U S A; 1980 Jan 15; 77(1):299-302. PubMed ID: 6928622
    [Abstract] [Full Text] [Related]

  • 7. 31P-MRS study of bio-energy recovering phenomenon.
    Yoshiyama M, Sakai H, Teragaki M, Takeuchi K, Takeda T, Ikata M, Ishikawa M, Miura I.
    Biochem Biophys Res Commun; 1988 Mar 15; 151(2):865-71. PubMed ID: 3348817
    [Abstract] [Full Text] [Related]

  • 8. Absolute quantification of phosphorus metabolite concentrations in human muscle in vivo by 31P MRS: a quantitative review.
    Kemp GJ, Meyerspeer M, Moser E.
    NMR Biomed; 2007 Oct 15; 20(6):555-65. PubMed ID: 17628042
    [Abstract] [Full Text] [Related]

  • 9. Influence of aging or left ventricular hypertrophy on the human heart: contents of phosphorus metabolites measured by 31P MRS.
    Okada M, Mitsunami K, Inubushi T, Kinoshita M.
    Magn Reson Med; 1998 May 15; 39(5):772-82. PubMed ID: 9581609
    [Abstract] [Full Text] [Related]

  • 10. [In-vivo 31P-NMR-spectroscopy in patients with dilated cardiomyopathy].
    Kaiser WA, Pauleit D, Träber F, Köhler U, Reiser M.
    Rofo; 1992 Nov 15; 157(5):458-65. PubMed ID: 1421186
    [Abstract] [Full Text] [Related]

  • 11. Magnetic resonance spectroscopy in congenital heart disease.
    Miall-Allen VM, Kemp GJ, Rajagopalan B, Taylor DJ, Radda GK, Haworth SG.
    Heart; 1996 Jun 15; 75(6):614-9. PubMed ID: 8697167
    [Abstract] [Full Text] [Related]

  • 12. Nuclear magnetic resonance spectroscopy of excised human hearts.
    Brunotte F, Peiffert B, Escanye JM, Pinelli G, Zamorano J, Walker PM, Robert J, Villemot JP.
    Br Heart J; 1992 Sep 15; 68(3):272-5. PubMed ID: 1389757
    [Abstract] [Full Text] [Related]

  • 13. Reproducibility of human cardiac 31P-NMR spectroscopy.
    Lamb HJ, Doornbos J, den Hollander JA, Luyten PR, Beyerbacht HP, van der Wall EE, de Roos A.
    NMR Biomed; 1996 Aug 15; 9(5):217-27. PubMed ID: 9068003
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Noninvasive assessment of cardiomyopathy development with simultaneous measurement of topical 1H- and 31P-magnetic resonance spectroscopy.
    Toyo-oka T, Nagayama K, Suzuki J, Sugimoto T.
    Circulation; 1992 Jul 15; 86(1):295-301. PubMed ID: 1319856
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differences in nucleotide compartmentation and energy state in isolated and in situ rat heart: assessment by 31P-NMR spectroscopy.
    Williams JP, Headrick JP.
    Biochim Biophys Acta; 1996 Aug 07; 1276(1):71-9. PubMed ID: 8764892
    [Abstract] [Full Text] [Related]

  • 18. Human cardiac high-energy phosphate metabolite concentrations by 1D-resolved NMR spectroscopy.
    Bottomley PA, Atalar E, Weiss RG.
    Magn Reson Med; 1996 May 07; 35(5):664-70. PubMed ID: 8722817
    [Abstract] [Full Text] [Related]

  • 19. Proton-decoupled myocardial 31P NMR spectroscopy reveals decreased PCr/Pi in patients with severe hypertrophic cardiomyopathy.
    Sieverding L, Jung WI, Breuer J, Widmaier S, Staubert A, van Erckelens F, Schmidt O, Bunse M, Hoess T, Lutz O, Dietze GJ, Apitz J.
    Am J Cardiol; 1997 Aug 04; 80(3A):34A-40A. PubMed ID: 9293954
    [Abstract] [Full Text] [Related]

  • 20. Noninvasive detection and monitoring of regional myocardial ischemia in situ using depth-resolved 31P NMR spectroscopy.
    Bottomley PA, Herfkens RJ, Smith LS, Brazzamano S, Blinder R, Hedlund LW, Swain JL, Redington RW.
    Proc Natl Acad Sci U S A; 1985 Dec 04; 82(24):8747-51. PubMed ID: 3866249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.